NCT02009449 2024-11-15
IVY
Eli Lilly and Company
Phase 1 Completed
Eli Lilly and Company
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Maryland, Baltimore
Masonic Cancer Center, University of Minnesota
AHS Cancer Control Alberta
Mayo Clinic